A polymorphism of the corticotropin-releasing hormone receptor 1 (CRHR1) has been related to improved lung function during ICS treatment [43], instead, polymorphisms in the TBX21 gene are likely to be associated to an improvement in airway hyperresponsiveness [44]. This evidence concerns the gene CRHR1 and airway hyperresponsiveness.